Phase I study of vemurafenib in children with recurrent or progressive BRAFV600E mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002)

MLA

John Robertson Crawford, et al. Phase I Study of Vemurafenib in Children with Recurrent or Progressive BRAFV600E Mutant Brain Tumors: Pacific Pediatric Neuro-Oncology Consortium Study (PNOC-002). May 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4628697167813dcf91e7b4f53c4a28c8&authtype=sso&custid=ns315887.

APA

John Robertson Crawford, Sabine Mueller, Michael D. Prados, Lindsay Kilburn, Janel Long-Boyle, Mariam Aboian, Jane E. Minturn, Theodore Nicolaides, Amar Gajjar, Annette M. Molinaro, Girish Dhall, Giles W. Robinson, Karen Gauvain, Kellie J. Nazemi, Hechuan Wang, & Sarah Leary. (2020). Phase I study of vemurafenib in children with recurrent or progressive BRAFV600E mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002).

Chicago

John Robertson Crawford, Sabine Mueller, Michael D. Prados, Lindsay Kilburn, Janel Long-Boyle, Mariam Aboian, Jane E. Minturn, et al. 2020. “Phase I Study of Vemurafenib in Children with Recurrent or Progressive BRAFV600E Mutant Brain Tumors: Pacific Pediatric Neuro-Oncology Consortium Study (PNOC-002),” May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4628697167813dcf91e7b4f53c4a28c8&authtype=sso&custid=ns315887.